PLUR Stock Analysis: Buy, Sell, or Hold?
$0.97
0.00 (0.02%)
▲
5d:
-11.8%
30d:
-36.59%
90d:
-53.58%
WAIT
LOW Confidence
Analysis Updated: Sep 29, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When PLUR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PLUR is down 11.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PLUR is down 11.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PLUR is currently trading at $0.97, which is considered oversold relative to its 30-day fair value range of $1.07 to $1.50.
Technical Outlook: Technically, PLUR is in a strong downtrend. Immediate support is located at $0.90, while resistance sits at $1.31.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.00 (+1137.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PLUR is in a strong downtrend. Immediate support is located at $0.90, while resistance sits at $1.31.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.00 (+1137.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.07 -
$1.50
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1137.0% below Wall St target ($12.00)
- WARNING: Composite score 47/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.07 -
$1.50
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.90
Resistance Level
$1.31
Current Trend
Strong Downtrend
Technical data as of
Sep 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.51
Wall Street Target
$12.00
(+1137.0%)
Revenue Growth (YoY)
-15.8%
Share & Embed Analysis
Last updated: September 29, 2026 12:20 PM ET
Data refreshes hourly during market hours. Next update: 1:20 PM
Data refreshes hourly during market hours. Next update: 1:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PLUR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 64 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$75 | 56 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$28 | 55 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$52 | 69 BUY |